Publications by authors named "L Zrinzo"

Introduction: Rising NHS waiting lists are a major problem following the COVID-19 pandemic. In our institution, surgical waiting time for elective functional neurosurgical procedures, such as deep brain stimulation (DBS) and radiofrequency ablation (RFA), reached >1.5 years by the end of 2022.

View Article and Find Full Text PDF
Article Synopsis
  • Cell and gene therapies have a wide range of potential applications, but their effectiveness hinges on careful consideration of clinical and surgical factors in both clinical trials and real-world use.
  • Key factors include accurate diagnosis, disease stage, and existing health conditions, which can complicate treatment and trial designs.
  • The chapter focuses particularly on challenges encountered in treating Parkinson's disease and other neurodegenerative disorders, though the insights may apply to various other medical conditions.
View Article and Find Full Text PDF

Background: Since their introduction in 2015, directional leads have practically replaced conventional leads for deep brain stimulation (DBS) in Parkinson's disease (PD). Yet, the benefits of directional DBS (dDBS) over omnidirectional DBS (oDBS) remain unclear. This meta-analysis and systematic review compares the literature on dDBS and oDBS for PD.

View Article and Find Full Text PDF

Background: Pharmaco-psychiatric techniques remain the mainstay, first line treatments in substance use disorders (SUD), assisting in detoxification but largely ineffective at reducing dependence. The path to rehabilitation and freedom from addiction often proves uncertain and laborious for both patients and their significant others. Relapse rates for multiple substances of abuse are considerable and the number of SUD patients is on the increase worldwide.

View Article and Find Full Text PDF

Objective: Laryngeal dystonia (LD), previously termed spasmodic dysphonia, is an isolated focal dystonia that involves involuntary, uncontrolled contractions of the laryngeal muscles during speech. It is a severely disabling condition affecting patients' work and social lives through prevention of normal speech production. Our understanding of the pathophysiology of LD and available therapeutic options are currently limited.

View Article and Find Full Text PDF